Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term women. Found 61 abstracts

paginate
Flynn KE, Carter J, Lin L, Lindau ST, Jeffery DD, Reese JB, Schlosser BJ, Weinfurt KP. Assessment of vulvar discomfort with sexual activity among women in the United States. American journal of obstetrics and gynecology. 2017 Apr;216(4):391 e1-391 e8.   PMCID: PMC5376372
Benson A, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA. Anal Carcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):449-54.   PMCID: not NIH funded
Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S, Rowan B, Van Decker S, Schmidheiser H, Bealin L, Sicilia P, Daly MB. Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment. 2012 Dec;136(3):749-57.   PMCID: PMC 3513641
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen XW, Bove B, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P. Identification of fifteen novel germline variants in the BRCA1 3 ' UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation. 2012 Dec;33(12):1665-75.
Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, Schildkraut J, Daly MB, Isaacs C, Pichert G, Neuhausen SL, Couch FJ, van't Veer L, Eeles R, Bancroft E, Evans DG, Ganz PA, Tomlinson GE, Narod SA, Matloff E, Domchek S, Rebbeck TR. Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers. Journal of Clinical Oncology. 2012 Apr;30(12):1321-8.   PMCID: PMC3341145
Freedman GM, Anderson PR, Bleicher RJ, Litwin S, Li TY, Swaby RF, Ma CM, Li JS, Sigurdson ER, Watkins-Bruner D, Morrow M, Goldstein LJ. Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(4):888-93.   PMCID: PMC3419789
Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer. 2012 Jan;118(2):478-84.   PMCID: PMC3195866
Hudson SV, Miller SM, Hemler J, Ferrante JM, Lyle J, Oeffinger KC, DiPaola RS. Adult Cancer Survivors Discuss Follow-up in Primary Care: 'Not What I Want, But Maybe What I Need'. Annals of Family Medicine. 2012 Sep;10(5):418-27.   PMCID: PMC3438209
Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2012 Apr;118(8):2021-30.   PMCID: PMC3245774
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang XS, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology Biomarkers & Prevention. 2012 Jan;21(1):134-47.   PMCID: PMC3272407
Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer. The oncologist. 2012 Jun;17(6):775-82.   PMCID: PMC3380876
Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW, Sparano JA. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Research and Treatment. 2012 Jul;134(2):683-92.   PMCID: PMC 3552372
Wen KY, Miller SM, Stanton AL, Fleisher L, Morra ME, Jorge A, Diefenbach MA, Ropka ME, Marcus AC. The development and preliminary testing of a multimedia patient-provider survivorship communication module for breast cancer survivors. Patient education and counseling. 2012 Aug;88(2):344-9.   PMCID: PMC3419388
Myers RE, Manne SL, Wilfond B, Sifri R, Ziring B, Wolf TA, Cocroft J, Ueland A, Petrich A, Swan H, DiCarlo M, Weinberg DS. A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: Trial design and baseline findings. Contemporary clinical trials. 2011 Jan;32(1):25-31.   PMCID: PMC3006063
Smith LD, Tesoriero AA, Wong EM, Ramus SJ, O'Malley FP, Mulligan AM, Terry MB, Senie RT, Santella RM, John EM, Andrulis IL, Ozcelik H, Daly MB, Godwin AK, Buys SS, Fox S, Goldgar DE, Giles GG, Hopper JL, Southey MC. Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast Cancer Research. 2011 Jan;13(1):R14.   PMCID: PMC3109582
Wang C, Gallo RE, Fleisher L, Miller SM. Literacy Assessment of Family Health History Tools for Public Health Prevention. Public Health Genomics. 2011 Jan;14(4-5):222-37.   PMCID: PMC2891255
Abramowitz MC, Li TY, Morrow M, Anderson PR, Bleicher RJ, Goldstein LJ, Swaby R, Nicoloau N, Freedman GM. History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer. Breast Journal. 2010 Jul;16(4):344-9.   PMCID: not NIH funded
Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR. Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Research and Treatment. 2010 Nov;124(1):195-203.   PMCID: PMC2949487
Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation a systematic review and meta-analysis. Tobacco Control. 2010 Oct;19(5):410-6.   PMCID: PMC2947553
Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA, Manning C, Ross E, Shannon K, Chung DC. Facilitating Informed Decisions Regarding Microsatellite Instability Testing Among High-Risk Individuals Diagnosed With Colorectal Cancer. Journal of Clinical Oncology. 2010 Mar;28(8):1366-72.   PMCID: PMC2834496
Ropka ME, Keim J, Philbrick JT. Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 2010 Jun;28(18):3090-5.   PMCID: PMC2903338
Sauter ER, Klein-Szanto A, MacGibbon B, Ehya H. Nipple Aspirate Fluid and Ductoscopy to Detect Breast Cancer. Diagnostic Cytopathology. 2010 Apr;38(4):244-51.   PMCID: NIHMS141667
Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W, Levine EA. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. BREAST JOURNAL. 2006 Jul;12(4):309-23.
Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: A multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. JOURNAL OF CLINICAL ONCOLOGY. 2006 May;24(14):2209-15.
Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly M, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade O, Weber BL, Rebbeck TR. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. LANCET ONCOLOGY. 2006 Mar;7(3):223-9.
Friedman E, Kotsopoulos J, Lubinski J, T Lynch H, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, D Foulkes W, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. BREAST CANCER RESEARCH. 2006 Jan;8(2):Art.
Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International journal of cancer. 2006 May;118(9):2281-4.
Manne SL, Ostroff JS, Norton TR, Fox K, Goldstein L, Grana G. Cancer-related relationship communication in couples coping with early stage breast cancer. PSYCHO-ONCOLOGY. 2006 Mar;15(3):234-47.
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006 Aug;15(8):1565-7.
Fernandez SV, Russo IH, Lareef M, Balsara B, Russo J. Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. International Journal of Oncology. 2005 Mar;26(3):691-5.
Kell MR, Morrow M. An adequate margin of excision in ductal carcinoma in situ - 2 mm plus radiotherapy is as good as a bigger margin. British Medical Journal. 2005 Oct 08;331(7520):789-90.
Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH. Breast differentiation and its implication in cancer prevention. Clinical Cancer Research. 2005 Jan 15;11(2):931S-936S.
Katz ML, Ruzek SB, Miller SM, Legos P. Gender differences in patients needs and concerns to diagnostic tests for possible cancer. Journal of Cancer Education. 2004 Jan;19(4):227-31.
Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med. 2004 Jul;39(1):36-47.
Sauter ER, Klein-Szanto A, Ehya H, MacGibbon B. Ductoscopic cytology and image analysis to detect breast carcinoma. Cancer. 2004 Sep 15;101(6):1283-92.
Wallace SG, Goldstein LJ. Nonepithelial malignancies of the breast - The Chugh/Baker article reviewed. ONCOLOGY-NEW YORK. 2004 May;18(5):675-6.
Whittemore AS, Balise RR, Pharoah PD, DiCioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 2004 Nov 29;91(11):1911-5.
Fang CY, Miller SM, Daly MB, Hurley K. The influence of attentional style and risk perceptions on intentions to undergo prophylactic oophorectomy among first- degree relatives. Psychology & Health. 2002 Jun;17(3):365-76.
Daly M. NCCN practice guidelines: Genetics/familial high-risk cancer screening. Oncology-New York. 1999 Nov;13(11A):161-82.
Fowble B, Hanlon A, Freedman G, Patchefsky A, Kessler H, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Journal of Clinical Oncology. 1999 Jun;17(6):1680-8.
Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (London, England). 1999 Nov 27;354(9193):1846-50.
Manne SL. Intrusive thoughts and psychological distress among cancer patients: The role of spouse avoidance and criticism. Journal of Consulting and Clinical Psychology. 1999 Aug;67(4):539-46.
Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute. 1999 Sep;91(17):1475-9.
Savard J, Miller SM, Mills M, O'Leary A, Harding H, Douglas SD, Mangan CE, Belch R, Winokur A. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosomatic Medicine. 1999 Jul;61(4):496-507.
Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: The impact on self-reported mammography use. American journal of public health. 1999 Jun;89(6):924-6.
Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 1998 May 20;90(10):761-6.
Miller SM, Mischel W, Schroeder CM, Buzaglo JS, Hurley K, Schreiber P, Mangan CE. Intrusive and avoidant ideation among females pursuing infertility treatment. Psychology & Health. 1998 Jan;13(5):847-58.
Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study. American journal of human genetics. 1998 Jun;62(6):1381-8.
Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E. Prostate-specific antigen production in the female breast: Association with progesterone. Cancer Epidemiology Biomarkers & Prevention. 1998 Apr;7(4):315-20.
Shoda Y, Mischel W, Miller SM, Diefenbach M, Daly MB, Engstrom PF. Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. Journal of Clinical Psychology in Medical Settings. 1998 Mar;5(1):3-17.
Grisso JA, Kelsey JL, Obrien LA, Miles CG, Sidney S, Maislin G, LaPann K, Moritz D, Peters B, Hibberd A, Clancy M, Cotler J, DeLong W, Ecker M, Friedenberg ZB, Good R, Hummer C, Markman W, Mooar P, Stein H, Wohl M, Zaslow D. Risk factors for hip fracture in men. American journal of epidemiology. 1997 May;145(9):786-93.
Hanchak NA, Kessler HB, MacPherson S, Xuan S, Solin LJ. Screening mammography: Experience in a health maintenance organization. Radiology. 1997 Nov;205(2):441-5.
Zarghami N, Grass L, Sauter ER, Diamandis EP. Prostate-specific antigen in serum during the menstrual cycle. Clinical Chemistry. 1997 Oct;43(10):1862-7.
Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, Caporaso N. Investigation of mechanisms linking depressed mood to nicotine dependence. Addictive behaviors. 1996 Jan;21(1):9-19.
Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK. A randomized trial of breast cancer risk counseling: Interacting effects of counseling, educational level, and coping style. Health Psychology. 1996 Mar;15(2):75-83.
Fowble B. Long-Term Results of Conservative Surgery and Radiation for Early-Stage Breast-Cancer - What Have We Wrought. International Journal of Radiation Oncology Biology Physics. 1995 Sep 30;33(2):535-7.
Miller SM. Monitoring Versus Blunting Styles of Coping with Cancer Influence the Information Patients Want and Need About Their Disease - Implications for Cancer Screening and Management. Cancer. 1995 Jul 15;76(2):167-77.
Russo J, Russo IH. Hormonally Induced-Differentiation - a Novel-Approach to Breast-Cancer Prevention. Journal of cellular biochemistry. 1995 Jan;:58-64.
Lerman C, Daly M, Masny A, Balshem A. Attitudes About Genetic Testing for Breast-Ovarian Cancer Susceptibility. Journal of Clinical Oncology. 1994 Apr;12(4):843-50.
Russo J, Romero AL, Russo IH. Architectural Pattern of the Normal and Cancerous Breast under the Influence of Parity. Cancer Epidemiology Biomarkers & Prevention. 1994 Apr;3(3):219-24.
Daly M, Seay J, Balshem A, Lerman C, Engstrom P. Feasibility of a Telephone Survey to Recruit Health Maintenance Organization Members into a Tamoxifen Chemoprevention Trial. Cancer Epidemiology Biomarkers & Prevention. 1992 Jul;1(5):413-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term women

women risk breast-cancer cancer Oncology ovarian-cancer age breast cancer psychological distress surgery information survival carcinoma tamoxifen gene germline mutations mammography quality-of-life prevention history strategies diagnosis stress health nipple aspirate fluid mutation carriers patterns BRCA1 families support impact cells therapy cigarette-smoking radiotherapy participation mutations randomized trial oophorectomy BRCA2 coping style analysis estrogen-receptor status coping styles colon-cancer breast neoplasms prostate radiation cost-effectiveness prophylactic oophorectomy distress markers risk-factors african-americans brca1 fiberoptic ductoscopy carcinogenesis susceptibility family history smoking cessation irradiation trial seeking population features intraepithelial neoplasia hysterectomy mortality biopsy hereditary breast management residual cancer discharge exercise colorectal-cancer sex anxiety Young age Breast cancer-Delay in diagnosis-Breast cancer screening African American distinct regions brca mutation health-care binding protein hur risk reduction Web-based patient education Patient-provider communication-Formative evaluation-Usability testing-Breast cancer survivorship f-18 fdg pet reduces natural-killer monitoring genome-wide association predisposition review article estrogen-receptor local recurrence v79 cells enrollment cell transformation trends Breast conservation treatment Early stage breast carcinoma-Radiation treatment-21-Gene recurrence score-Local recurrence-Local-regional recurrence rat mammary-gland familial breast carrier frequency veterans breast- Patient Reported Outcomes Measurement Information System avoidant parity diagnostic radiology proximal femur association attitudes falls classification sexual function self-examination sleep estrogen hip fractures hypogonadism Patient Reported Outcomes Measurement Information System Sexual Function and morbidity prostate cancer Satisfaction 4-OH-E-2 ashkenazi-jewish individuals physical impairment cancer survivors cancer screening-primary health care-qualitative research-patient-centered care-continuity of patient care-breast neoplasms-prostate neoplasms physical symptoms nicotine gum determinant salpingo-oophorectomy ovarian cancer treatment mutation hamster tissues community lung-cancer tobacco smoking chemical carcinogens enhancement therapy quality penetrance genetic epidemiology myocardial-infarction 1969 laughlin gh-v12-p639 microrna targets stage breast-cancer communication health information family germline
Last updated on Saturday, August 08, 2020